SlideShare a Scribd company logo
1 of 44
The unity of all science consists
alone in the method, not its material.
Pearson K. The grammar of science. London, Black, 1892.
Statistics is the study of uncertainty.
Savage LJ. The foundations of statistics. New York, Wiley,
1954.
The aim of statistics reviewing
Accurate and transparent description of the uncertainty in
presented findings.




“Statisticians are experts in handling uncertainty”.

Lindley DV. The philosophy of statistics. The Statistician 2000;49:293-337.
Medical research methodology


                      Ethics concerns
                      Randomization
Experi-             Controlled conditions
mental                Internal validity
                      Short follow up
                   Sample size restrictions
Study
design


Obser-               Few ethics concerns
vational               Bias adjustments
                       External validity
                        Long follow up
                  Few sample size restrictions
Statistical aspects – internal validity


                    Internal validity by design (blocking of
Experi-            known risk factors and randomization of
mental                                other)

                     Potential for confounding: none
Study
design

                      Internal validity by statistical analysis
Obser-              (confounding adjustment for known and
vational                     measured risk factors)

                    Potential for confounding: massive
Confounder (or case-mix) adjustment
How much of the variation in endpoints can be explained by known
factors, and how much has unknown causes?


Variation with unknown origin

95%-99%       Arthroplasty revision

85%-95%       EQ-5D, SF36

70%-80%       Coronary heart disease
Risk factors, confounding, and the
illusion of statistical control
'...it is essential to remember that “statistical control” is nothing more
than a highly fallible process filled with judgment calls that often go
unnoticed in practice.'




Christenfeld NJS, Sloan RP, Carrol D, Greenland S.
Psychosomatic Medicine 2004;66:868–875
Linear regression analysis




Simple model
                             Multiple model
                 (or multivariable, but not multivariate)
Stepwise regression
Statistics
We calculated odds ratios by logistic regression
analysis, to estimate the relationship between
failure of the osteotomy and possible preoperative
risk factors. We performed multivariate, stepwise
(backward) logistic regression and entered
variables with a p-value of ≤ 0.05 into the model.
Unified theory of bias
Bias can be reduced to or explained by 3 structures

1. Reverse causation

Outcome precedes exposure measurement or outcome can have
effect on exposure. Measurement error or Information bias.

2. Common cause

Confounding by association, confounding by indication.

3. Conditioning on common effects

Collider, selection bias, time varying confounding.
Covariate selection
Adequate Background Knowledge

Confounder identification must be based on understanding of the
causal structure linking the variables being studied (treatment and
disease).

Condition on the minimal set of variables necessary to remove
confounding.

Inadequate Background Knowledge

Remove known instrumental variables, colliders, intermediates
(variables with post treatment measurement.
Confounding
Under-adjustment

occurs when a confounder is not adjusted for.

Over-adjustment

can occur from adjusting instrumental variables, intermediate
variables, colliders, variables caused by outcome.
Confounder
Common cause, i.e., confounder

Confounder L distort the effect of
treatment A on disease Y

Always adjust for confounders, unless
small data set and confounder has
strong association with treatment and
week association with outcome
Confounder example
A = treatment
1: statin alone
0: niacin alone

L = Baseline Cholesterol
1: LDL ≥ 160 mg/dL
0: LDL < 160 mg/dL

Y = Myocardial infarction
1: Yes
0: No
Intermediate variable
Adjusting for intermediate variable I in a
fixed covariate model will remove the effect
of treatment A on disease/outcome Y

In a fixed covariate model we do not want to
include variables influenced by A or Y
Intermediate example
A = treatment
1: statin alone
0: niacin alone

I = Post-treatment Cholesterol
1: LDL ≥ 160 mg/dL
0: LDL < 160 mg/dL

Y = Myocardial infarction
1: Yes
0: No
Collider
Adjusting for a collider can produce bias

Conditioning on common effect F without
adjustment of U1 or U2 will induce an
association between U1 and U2, which will
confound the association between A and Y
Collider example
Variables associated with
treatment or disease only
Inclusion of variables associated with treatment only can cause bias
and imprecision

Variables associated with disease but not treatment (risk factors)
can be included in models. They are expected to decrease variance
of treatment effect without increasing bias

Including variables associated with disease reduces the chance of
missing important confounders
Reality is complicated
http://www.dagitty.net
http://www.dagitty.net
Any claim coming from an observational study is
most likely to be wrong

12 randomised trials have tested 52 observational claims (about the
effects of vitamine B6, B12, C, D, E, beta carotene, hormone replace-
ment therapy, folic acid and selenium).

“They all confirmed no claims in the direction of the observational
claim. We repeat that figure: 0 out of 52. To put it in another way,
100% of the observational claims failed to replicate. In fact, five
claims (9.6%) are statistically significant in the opposite direction to
the observational claim.”




Young S, Karr A. Deming, data and observational studies.
Significance, September 2011.
Medical research methodology



  Hypothesis generation           Pre-specified hypotheses

       Exploration                       Confirmation

Academic analysis freedom           Legislation, regulatory
                                          guidelines

   Uncertainty tolerance           Uncertainty intolerance




           Aetiology       Study scope    Treatment
Medical research methodology



Experi-
              Laboratory                Randomized clinical
mental
             experiments                      trials


Study
design


Obser-
vational    Epidemiological                 Patient register
                studies                         studies




                  Aetiology   Study scope     Treatment
Statistical aspects - precision


             Bonferroni correction          Protected type-1 error rate
Experi-        within endpoints               for specified endpoints
mental
               Few type-2 error             Sample size based on the
                considerations                 type-2 error rate

Study
design
              Multiplicity issues          Specified type-1 and -2 error
Obser-         not addressed                        uncertainty
vational                                      (confidence intervals)
           Sample size not based on
              type-2 error rate            No multiplicity consideration
                                              for safety endpoints




                     Aetiology       Study scope    Treatment
Drug development

           Discovery
                       Phase 1
           (Phase 0)
                                       Phase 2
Experi-                                            Phase 3
mental
                                                             Phase 4


Study
design
                                                               PMS
                                                             (Phase 5)
Obser-
vational




                 Aetiology       Study scope     Treatment
Device development


           Biomechanics
            in vitro, etc.                       Randomized
Experi-                                          performance
mental                                               trials




Study
design
                                                              Safety
                                                            follow-up
Obser-                                                    in registries
vational




                Aetiology    Study orientation    Treatment
It is impossible to do clinical research so badly that
it cannot be published

“There seems to be no study too fragmented, no hypothesis too
trivial, no literature citation too biased or too egotistical, no design
too warped, no methodology too bungled, no presentation of
results too inaccurate, no argument too circular, no conclusions
too trifling or too unjustified, and no grammar and syntax too
offensive for a paper to end up in print.”




Drummond Rennie 1986 (editor of NEJM and JAMA)
Arthroplasty registry analyses
Crucial issues

-   Fulfillment of methodological assumptions (Gaussian distr,
    homogeneity of variance, proportionality, linearity, etc.)
-   Confounding adjustment (risk factors, causality, linearity, etc.)
-   Clinical significance and estimation uncertainty (95%CI).

Should be avoided

-   P-value culture
-   Bonferroni correction
-   Post-hoc power
-   Predictions
Thank you for your attention!
Indicators for statistical review
- Randomized trials

- Patient registry (safety) studies

- Analyses of knees, hips, elbows... (bilateral observations)

- Pseudo-replicates (esp. in laboratory experiments)

- “No difference” manuscripts

- Stepwise regression

- ???

More Related Content

What's hot

Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...
Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...
Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...Nawanan Theera-Ampornpunt
 
Study design in research
Study design in  research Study design in  research
Study design in research Kusum Gaur
 
Sudhakar singh meta analysis
Sudhakar singh meta analysisSudhakar singh meta analysis
Sudhakar singh meta analysisSudhakarSingh66
 
How to assess evidence
How to assess evidenceHow to assess evidence
How to assess evidenceRamy Ishaq
 
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)University of the Witwatersrand
 
Study design
Study designStudy design
Study designRSS6
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...Cytel USA
 
Study designs & amp; trials presentation1 2
Study designs & amp; trials presentation1 2Study designs & amp; trials presentation1 2
Study designs & amp; trials presentation1 2Praveen Ganji
 
Economic evaluation, reimbursement and context. How to assess personalised me...
Economic evaluation, reimbursement and context. How to assess personalised me...Economic evaluation, reimbursement and context. How to assess personalised me...
Economic evaluation, reimbursement and context. How to assess personalised me...HTAi Bilbao 2012
 
Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)ADITYA CHAKRABORTY
 
Research Methodology - Study Designs
Research Methodology - Study DesignsResearch Methodology - Study Designs
Research Methodology - Study DesignsAzmi Mohd Tamil
 
Research Methodology General.ppt
Research  Methodology  General.pptResearch  Methodology  General.ppt
Research Methodology General.pptShama
 
Clinical Trials in Russia Through Patients’ Eyes (ENG)
Clinical Trials in Russia Through Patients’ Eyes (ENG)Clinical Trials in Russia Through Patients’ Eyes (ENG)
Clinical Trials in Russia Through Patients’ Eyes (ENG)Evgeny Kulikov
 
Introduction to EBM
Introduction to EBMIntroduction to EBM
Introduction to EBMHMillward1
 

What's hot (20)

Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...
Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...
Systematic Reviews (Evidence-Based Medicine for Year 5 Ramathibodi Medical St...
 
Study design in research
Study design in  research Study design in  research
Study design in research
 
Sudhakar singh meta analysis
Sudhakar singh meta analysisSudhakar singh meta analysis
Sudhakar singh meta analysis
 
Evidence based orthodontics
Evidence based orthodonticsEvidence based orthodontics
Evidence based orthodontics
 
How to assess evidence
How to assess evidenceHow to assess evidence
How to assess evidence
 
study designs
 study designs study designs
study designs
 
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)
Neuropathic pain phenotyping by international consensus (NeuroPPIC) (2015)
 
Study design
Study designStudy design
Study design
 
Study design
Study designStudy design
Study design
 
Study designs 2013
Study designs 2013Study designs 2013
Study designs 2013
 
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
2014-10-22 EUGM | WEI | Moving Beyond the Comfort Zone in Practicing Translat...
 
Study designs & amp; trials presentation1 2
Study designs & amp; trials presentation1 2Study designs & amp; trials presentation1 2
Study designs & amp; trials presentation1 2
 
Kay Dickersin
Kay DickersinKay Dickersin
Kay Dickersin
 
Economic evaluation, reimbursement and context. How to assess personalised me...
Economic evaluation, reimbursement and context. How to assess personalised me...Economic evaluation, reimbursement and context. How to assess personalised me...
Economic evaluation, reimbursement and context. How to assess personalised me...
 
Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)Interim analysis in clinical trials (1)
Interim analysis in clinical trials (1)
 
Research Methodology - Study Designs
Research Methodology - Study DesignsResearch Methodology - Study Designs
Research Methodology - Study Designs
 
Study designs
Study designs Study designs
Study designs
 
Research Methodology General.ppt
Research  Methodology  General.pptResearch  Methodology  General.ppt
Research Methodology General.ppt
 
Clinical Trials in Russia Through Patients’ Eyes (ENG)
Clinical Trials in Russia Through Patients’ Eyes (ENG)Clinical Trials in Russia Through Patients’ Eyes (ENG)
Clinical Trials in Russia Through Patients’ Eyes (ENG)
 
Introduction to EBM
Introduction to EBMIntroduction to EBM
Introduction to EBM
 

Viewers also liked (18)

Copenhagen 2008
Copenhagen 2008Copenhagen 2008
Copenhagen 2008
 
Prague 02.10.2008
Prague 02.10.2008Prague 02.10.2008
Prague 02.10.2008
 
Lund 2009
Lund 2009Lund 2009
Lund 2009
 
Copenhagen 23.10.2008
Copenhagen 23.10.2008Copenhagen 23.10.2008
Copenhagen 23.10.2008
 
Sof stat issues_pro
Sof stat issues_proSof stat issues_pro
Sof stat issues_pro
 
Norsminde 2009
Norsminde 2009Norsminde 2009
Norsminde 2009
 
Oac beijing jr
Oac beijing jrOac beijing jr
Oac beijing jr
 
Lund 30.09.2008
Lund 30.09.2008Lund 30.09.2008
Lund 30.09.2008
 
Oarsi jr1
Oarsi jr1Oarsi jr1
Oarsi jr1
 
Abc4
Abc4Abc4
Abc4
 
London 21.11.2008
London 21.11.2008London 21.11.2008
London 21.11.2008
 
London 2008
London 2008London 2008
London 2008
 
Amsterdam 2008
Amsterdam 2008Amsterdam 2008
Amsterdam 2008
 
Odense 2010
Odense 2010Odense 2010
Odense 2010
 
Amsterdam 11.06.2008
Amsterdam 11.06.2008Amsterdam 11.06.2008
Amsterdam 11.06.2008
 
Karlskrona 2009
Karlskrona 2009Karlskrona 2009
Karlskrona 2009
 
Rcsyd pres nara
Rcsyd pres naraRcsyd pres nara
Rcsyd pres nara
 
Stockholm 6 7.11.2008
Stockholm 6 7.11.2008Stockholm 6 7.11.2008
Stockholm 6 7.11.2008
 

Similar to Malmo 30 03-2012

Comparing Research Designs
Comparing Research DesignsComparing Research Designs
Comparing Research DesignsPat Barlow
 
4 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia20074 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia2007KhanhHoa Tran
 
Basics statistics
Basics statistics Basics statistics
Basics statistics BITS
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidenceCatherineVoutier
 
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdfEffective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdfPubrica
 
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpostFo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpostCinnamonBloss
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsKarin Verspoor
 
Concussion guidelines article. Carney et al. Neurosurgery 2014
Concussion guidelines article. Carney et al. Neurosurgery 2014Concussion guidelines article. Carney et al. Neurosurgery 2014
Concussion guidelines article. Carney et al. Neurosurgery 2014brwjam004
 
Case control study by keshab chapagain
Case control study by keshab chapagainCase control study by keshab chapagain
Case control study by keshab chapagainKeshab Chapagain
 
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapyGuillem Feixas
 
Introduction - Evidence-Based Medicine for Haematology
Introduction - Evidence-Based Medicine for HaematologyIntroduction - Evidence-Based Medicine for Haematology
Introduction - Evidence-Based Medicine for HaematologyRobin Featherstone
 

Similar to Malmo 30 03-2012 (20)

Comparing Research Designs
Comparing Research DesignsComparing Research Designs
Comparing Research Designs
 
4 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia20074 primaryresearchquestionanddefinitionofendpointsindia2007
4 primaryresearchquestionanddefinitionofendpointsindia2007
 
Basics statistics
Basics statistics Basics statistics
Basics statistics
 
HLinc presentation: levels of evidence
HLinc presentation:  levels of evidenceHLinc presentation:  levels of evidence
HLinc presentation: levels of evidence
 
02 basic researchmethod
02 basic researchmethod02 basic researchmethod
02 basic researchmethod
 
Searching EBM Resources
Searching EBM ResourcesSearching EBM Resources
Searching EBM Resources
 
A tool to measure the success of patient handling interventions
A tool to measure the success of patient handling interventionsA tool to measure the success of patient handling interventions
A tool to measure the success of patient handling interventions
 
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdfEffective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
 
Nara guidelines-jr
Nara guidelines-jrNara guidelines-jr
Nara guidelines-jr
 
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpostFo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
Fo gm vi-cinnamonbloss_idiom_7march2013_fina_lpost
 
Coursebooklet
CoursebookletCoursebooklet
Coursebooklet
 
Prague 2008
Prague 2008Prague 2008
Prague 2008
 
RSS 2012 Study designs
RSS 2012 Study designsRSS 2012 Study designs
RSS 2012 Study designs
 
METHODOLOGY IN RESEARCH
METHODOLOGY IN RESEARCHMETHODOLOGY IN RESEARCH
METHODOLOGY IN RESEARCH
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questions
 
Concussion guidelines article. Carney et al. Neurosurgery 2014
Concussion guidelines article. Carney et al. Neurosurgery 2014Concussion guidelines article. Carney et al. Neurosurgery 2014
Concussion guidelines article. Carney et al. Neurosurgery 2014
 
Case control study by keshab chapagain
Case control study by keshab chapagainCase control study by keshab chapagain
Case control study by keshab chapagain
 
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy
2011 pcp boston_changes_in_the_personal_construct_system_during_psychotherapy
 
20081206 Appraisal
20081206 Appraisal20081206 Appraisal
20081206 Appraisal
 
Introduction - Evidence-Based Medicine for Haematology
Introduction - Evidence-Based Medicine for HaematologyIntroduction - Evidence-Based Medicine for Haematology
Introduction - Evidence-Based Medicine for Haematology
 

More from Jonas Ranstam PhD (10)

Sof klin forsk_stat
Sof klin forsk_statSof klin forsk_stat
Sof klin forsk_stat
 
Oac guidelines
Oac guidelinesOac guidelines
Oac guidelines
 
Lund 2010
Lund 2010Lund 2010
Lund 2010
 
Lecture jr
Lecture jrLecture jr
Lecture jr
 
Datavalidering jr1
Datavalidering jr1Datavalidering jr1
Datavalidering jr1
 
Brussels 2010
Brussels 2010Brussels 2010
Brussels 2010
 
Actalecturerungsted
ActalecturerungstedActalecturerungsted
Actalecturerungsted
 
Umeapresjr
UmeapresjrUmeapresjr
Umeapresjr
 
Malmo 17.10.2008
Malmo 17.10.2008Malmo 17.10.2008
Malmo 17.10.2008
 
Malmo 11.11.2008
Malmo 11.11.2008Malmo 11.11.2008
Malmo 11.11.2008
 

Malmo 30 03-2012

  • 1. The unity of all science consists alone in the method, not its material. Pearson K. The grammar of science. London, Black, 1892.
  • 2. Statistics is the study of uncertainty. Savage LJ. The foundations of statistics. New York, Wiley, 1954.
  • 3. The aim of statistics reviewing Accurate and transparent description of the uncertainty in presented findings. “Statisticians are experts in handling uncertainty”. Lindley DV. The philosophy of statistics. The Statistician 2000;49:293-337.
  • 4. Medical research methodology Ethics concerns Randomization Experi- Controlled conditions mental Internal validity Short follow up Sample size restrictions Study design Obser- Few ethics concerns vational Bias adjustments External validity Long follow up Few sample size restrictions
  • 5. Statistical aspects – internal validity Internal validity by design (blocking of Experi- known risk factors and randomization of mental other) Potential for confounding: none Study design Internal validity by statistical analysis Obser- (confounding adjustment for known and vational measured risk factors) Potential for confounding: massive
  • 6. Confounder (or case-mix) adjustment How much of the variation in endpoints can be explained by known factors, and how much has unknown causes? Variation with unknown origin 95%-99% Arthroplasty revision 85%-95% EQ-5D, SF36 70%-80% Coronary heart disease
  • 7. Risk factors, confounding, and the illusion of statistical control '...it is essential to remember that “statistical control” is nothing more than a highly fallible process filled with judgment calls that often go unnoticed in practice.' Christenfeld NJS, Sloan RP, Carrol D, Greenland S. Psychosomatic Medicine 2004;66:868–875
  • 8. Linear regression analysis Simple model Multiple model (or multivariable, but not multivariate)
  • 10.
  • 11.
  • 12. Statistics We calculated odds ratios by logistic regression analysis, to estimate the relationship between failure of the osteotomy and possible preoperative risk factors. We performed multivariate, stepwise (backward) logistic regression and entered variables with a p-value of ≤ 0.05 into the model.
  • 13. Unified theory of bias Bias can be reduced to or explained by 3 structures 1. Reverse causation Outcome precedes exposure measurement or outcome can have effect on exposure. Measurement error or Information bias. 2. Common cause Confounding by association, confounding by indication. 3. Conditioning on common effects Collider, selection bias, time varying confounding.
  • 14. Covariate selection Adequate Background Knowledge Confounder identification must be based on understanding of the causal structure linking the variables being studied (treatment and disease). Condition on the minimal set of variables necessary to remove confounding. Inadequate Background Knowledge Remove known instrumental variables, colliders, intermediates (variables with post treatment measurement.
  • 15. Confounding Under-adjustment occurs when a confounder is not adjusted for. Over-adjustment can occur from adjusting instrumental variables, intermediate variables, colliders, variables caused by outcome.
  • 16. Confounder Common cause, i.e., confounder Confounder L distort the effect of treatment A on disease Y Always adjust for confounders, unless small data set and confounder has strong association with treatment and week association with outcome
  • 17. Confounder example A = treatment 1: statin alone 0: niacin alone L = Baseline Cholesterol 1: LDL ≥ 160 mg/dL 0: LDL < 160 mg/dL Y = Myocardial infarction 1: Yes 0: No
  • 18. Intermediate variable Adjusting for intermediate variable I in a fixed covariate model will remove the effect of treatment A on disease/outcome Y In a fixed covariate model we do not want to include variables influenced by A or Y
  • 19. Intermediate example A = treatment 1: statin alone 0: niacin alone I = Post-treatment Cholesterol 1: LDL ≥ 160 mg/dL 0: LDL < 160 mg/dL Y = Myocardial infarction 1: Yes 0: No
  • 20. Collider Adjusting for a collider can produce bias Conditioning on common effect F without adjustment of U1 or U2 will induce an association between U1 and U2, which will confound the association between A and Y
  • 22. Variables associated with treatment or disease only Inclusion of variables associated with treatment only can cause bias and imprecision Variables associated with disease but not treatment (risk factors) can be included in models. They are expected to decrease variance of treatment effect without increasing bias Including variables associated with disease reduces the chance of missing important confounders
  • 26.
  • 27. Any claim coming from an observational study is most likely to be wrong 12 randomised trials have tested 52 observational claims (about the effects of vitamine B6, B12, C, D, E, beta carotene, hormone replace- ment therapy, folic acid and selenium). “They all confirmed no claims in the direction of the observational claim. We repeat that figure: 0 out of 52. To put it in another way, 100% of the observational claims failed to replicate. In fact, five claims (9.6%) are statistically significant in the opposite direction to the observational claim.” Young S, Karr A. Deming, data and observational studies. Significance, September 2011.
  • 28.
  • 29. Medical research methodology Hypothesis generation Pre-specified hypotheses Exploration Confirmation Academic analysis freedom Legislation, regulatory guidelines Uncertainty tolerance Uncertainty intolerance Aetiology Study scope Treatment
  • 30. Medical research methodology Experi- Laboratory Randomized clinical mental experiments trials Study design Obser- vational Epidemiological Patient register studies studies Aetiology Study scope Treatment
  • 31. Statistical aspects - precision Bonferroni correction Protected type-1 error rate Experi- within endpoints for specified endpoints mental Few type-2 error Sample size based on the considerations type-2 error rate Study design Multiplicity issues Specified type-1 and -2 error Obser- not addressed uncertainty vational (confidence intervals) Sample size not based on type-2 error rate No multiplicity consideration for safety endpoints Aetiology Study scope Treatment
  • 32. Drug development Discovery Phase 1 (Phase 0) Phase 2 Experi- Phase 3 mental Phase 4 Study design PMS (Phase 5) Obser- vational Aetiology Study scope Treatment
  • 33. Device development Biomechanics in vitro, etc. Randomized Experi- performance mental trials Study design Safety follow-up Obser- in registries vational Aetiology Study orientation Treatment
  • 34. It is impossible to do clinical research so badly that it cannot be published “There seems to be no study too fragmented, no hypothesis too trivial, no literature citation too biased or too egotistical, no design too warped, no methodology too bungled, no presentation of results too inaccurate, no argument too circular, no conclusions too trifling or too unjustified, and no grammar and syntax too offensive for a paper to end up in print.” Drummond Rennie 1986 (editor of NEJM and JAMA)
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40. Arthroplasty registry analyses Crucial issues - Fulfillment of methodological assumptions (Gaussian distr, homogeneity of variance, proportionality, linearity, etc.) - Confounding adjustment (risk factors, causality, linearity, etc.) - Clinical significance and estimation uncertainty (95%CI). Should be avoided - P-value culture - Bonferroni correction - Post-hoc power - Predictions
  • 41.
  • 42. Thank you for your attention!
  • 43.
  • 44. Indicators for statistical review - Randomized trials - Patient registry (safety) studies - Analyses of knees, hips, elbows... (bilateral observations) - Pseudo-replicates (esp. in laboratory experiments) - “No difference” manuscripts - Stepwise regression - ???

Editor's Notes

  1. Reichenback talks about principles of common causes.
  2. Modulate inflammatory response Prevent thrombus formation
  3. Blocked backdoor path. F meets the criteria for traditional confounder, but it is not a counfounder and this is not a confounded study
  4. Causal null: whether having low education increases risk for type II diabetes. We measured mother’s diabetes status, but do not have measures of family income when the individual was growing up or if the mother had any genes that would increase the risk for diabetes. Under the assumptions in the DAG, should we adjust for mother’s diabetes status? Assumptions that if poor during childhood, then poor as adult and poor associated with diabetes and low education. Mother’s diabetes status will be statistically associated with education. They share a common prior cause. Meets criteria for statistical association Conditioning on mother’s diabetes unblocks the blocked backdoor path and induces a spurious statistical association between low education and diabetes. Does not meet criteria for graphical confounder. Basketball player tall or fast.
  5. Argue a high level of inductive reasoning here